Skip to main content

Table 2 Clinical characteristics of participants receiving care at Debre Markos and Felege Hiwot referral hospitals, Ethiopia, 2018–2019 (n = 186)

From: Effect of a self-care educational intervention to improve self-care adherence among patients with chronic heart failure: a clustered randomized controlled trial in Northwest Ethiopia

Variables

Control group (n = 98)

Treatment group (n = 88)

p values

Frequency (%)

Frequency (%)

Comorbidity

Yes

17 (17.3%)

32 (36.4%)

0.000

No

81 (82.7%)

56 (63.6%)

Current medication

Furosemide

87 (88.8%)

88 (100%))

0.000

Spironolactone

76 (77.6%)

83 (94.3%)

ACE

42 (42.8%)

55 (62.5%)

Aspirin

44 (44.9%)

12 (13.6%)

Lipid lowering drugs

18 (18.3%)

12 (13.6%)

Beta blockers

51 (52%)

44 (50%)

History of hospitalization

Yes

67 (68.4%)

71 (80.7%)

0.06

No

31 (31.6%)

17 (19.3%)

Chronic heart failure stage

One

5 (5.7%)

0.000

Two

3 (3.1%)

14 (15.9%)

Three

19 (19.4%)

21 (23.9%)

Four

76 (77.6%)

48 (54.5%)

  1. ACE: Angiotensin converting enzyme inhibitors. In this study ACE inhibitors were captopril and enalapril
  2. Beta blockers were atenolol, metoprolol, and propranolol